ArticleScientific reports2026
OCT-based optic neuropathy diagnosis using explainable and privacy-preserving machine learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glaucoma shares similarities with neurodegenerative conditions like dementia, Parkinson's disease, and ischaemic optic neuropathy, which affect ocular health. However, current studies exclude neurodegenerative cases in neuropathy diagnosis and rely on 'black box' models. To address this, we applied explainable machine learning to optical coherence tomography (OCT) data, integrating a privacy-preserving mechanism to create a reliable neuropathy diagnostic tool. OCT data from 268 glaucomatous, 334 normal, 56 dementia, 60 Parkinson's, and 93 ION eyes were analysed from a Sydney-based eye clinic. Spatial and frequency domain features were extracted, followed by feature selection and hierarchical classification. Model interpretability was enhanced using SHapley Additive exPlanations and partial dependency analysis, and privacy was preserved incorporating a differential privacy mechanism. A team of three clinicians, with 12, 11, and 6 years of experience, evaluated their performance on the same dataset for a human versus machine comparison, with the machine achieving an area under the curve of 0.90 for classifying neuropathy. Overall, machine outperformed clinicians, with 26.3% higher accuracy for neuropathy and 24.8% higher accuracy for glaucoma diagnosis. In conclusion, both non-explainable and explainable methods show promise in enhancing diagnostic support for clinical decision-making, with the privacy-preserving approach safeguarding data privacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.